Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
0.3403 x 2 0.3500 x 2
Post-market by (Cboe BZX)
0.3437 +0.0037 (+1.09%) 04/23/25 [NASDAQ]
0.3403 x 2 0.3500 x 2
Post-market 0.3499 +0.0062 (+1.80%) 17:03 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3417
Day High
0.3611
Open 0.3479
Previous Close 0.3400 0.3400
Volume 935,690 935,690
Avg Vol 1,844,535 1,844,535
Stochastic %K 40.17% 40.17%
Weighted Alpha -62.77 -62.77
5-Day Change -0.0117 (-3.29%) -0.0117 (-3.29%)
52-Week Range 0.2850 - 1.0700 0.2850 - 1.0700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 77,591
  • Shares Outstanding, K 228,208
  • Annual Sales, $ 28,700 K
  • Annual Income, $ -66,950 K
  • EBIT $ -66 M
  • EBITDA $ -58 M
  • 60-Month Beta 1.57
  • Price/Sales 2.53
  • Price/Cash Flow N/A
  • Price/Book 1.23
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings $-0.05 on 03/20/25
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 264.36% ( +20.78%)
  • Historical Volatility 105.91%
  • IV Percentile 86%
  • IV Rank 55.05%
  • IV High 455.61% on 07/18/24
  • IV Low 30.12% on 10/22/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 187
  • Volume Avg (30-Day) 226
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 6,927
  • Open Int (30-Day) 11,324

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2850 +20.60%
on 04/09/25
Period Open: 0.5161
0.5440 -36.82%
on 03/24/25
-0.1724 (-33.40%)
since 03/21/25
3-Month
0.2850 +20.60%
on 04/09/25
Period Open: 0.7697
0.8099 -57.56%
on 01/24/25
-0.4260 (-55.35%)
since 01/23/25
52-Week
0.2850 +20.60%
on 04/09/25
Period Open: 0.7454
1.0700 -67.88%
on 09/16/24
-0.4017 (-53.89%)
since 04/23/24

Most Recent Stories

More News
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23

VXRT : 0.3437 (+1.09%)
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VXRT : 0.3437 (+1.09%)
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

VXRT : 0.3437 (+1.09%)
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

VXRT : 0.3437 (+1.09%)
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

VXRT : 0.3437 (+1.09%)
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

VXRT : 0.3437 (+1.09%)
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

VXRT : 0.3437 (+1.09%)
Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

VXRT : 0.3437 (+1.09%)
Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

VXRT : 0.3437 (+1.09%)
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

VXRT : 0.3437 (+1.09%)

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

3rd Resistance Point 0.3754
2nd Resistance Point 0.3682
1st Resistance Point 0.3560
Last Price 0.3437
1st Support Level 0.3366
2nd Support Level 0.3294
3rd Support Level 0.3172

See More

52-Week High 1.0700
Fibonacci 61.8% 0.7701
Fibonacci 50% 0.6775
Fibonacci 38.2% 0.5849
Last Price 0.3437
52-Week Low 0.2850

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective